Skip to main content
Journal cover image

Primary Analysis of TRAVERSE: A Phase 1/2a Study to Assess Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost HIV Vaccine Regimens

Publication ,  Conference
Stieh, DJ; Callewaert, K; Sarnecki, M; Hendriks, J; Nijs, S; Euler, Z; Schuitemaker, H; Tomaras, GD; Kublin, JG; Corey, L; McElrath, MJ ...
Published in: AIDS RESEARCH AND HUMAN RETROVIRUSES
October 1, 2018

Duke Scholars

Published In

AIDS RESEARCH AND HUMAN RETROVIRUSES

EISSN

1931-8405

ISSN

0889-2229

Publication Date

October 1, 2018

Volume

34

Start / End Page

18 / 18

Location

Madrid, SPAIN

Publisher

MARY ANN LIEBERT, INC

Conference Name

HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science

Related Subject Headings

  • Virology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stieh, D. J., Callewaert, K., Sarnecki, M., Hendriks, J., Nijs, S., Euler, Z., … Tomaka, F. L. (2018). Primary Analysis of TRAVERSE: A Phase 1/2a Study to Assess Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost HIV Vaccine Regimens. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 34, pp. 18–18). Madrid, SPAIN: MARY ANN LIEBERT, INC.
Stieh, Daniel J., Katleen Callewaert, Michal Sarnecki, Jenny Hendriks, Steven Nijs, Zelda Euler, Hanneke Schuitemaker, et al. “Primary Analysis of TRAVERSE: A Phase 1/2a Study to Assess Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost HIV Vaccine Regimens.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 34:18–18. MARY ANN LIEBERT, INC, 2018.
Stieh DJ, Callewaert K, Sarnecki M, Hendriks J, Nijs S, Euler Z, et al. Primary Analysis of TRAVERSE: A Phase 1/2a Study to Assess Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost HIV Vaccine Regimens. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 18–18.
Stieh, Daniel J., et al. “Primary Analysis of TRAVERSE: A Phase 1/2a Study to Assess Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost HIV Vaccine Regimens.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 34, MARY ANN LIEBERT, INC, 2018, pp. 18–18.
Stieh DJ, Callewaert K, Sarnecki M, Hendriks J, Nijs S, Euler Z, Schuitemaker H, Tomaras GD, Kublin JG, Corey L, McElrath MJ, Ake J, Robb ML, Alter G, Barouch DH, Pau MG, Tomaka FL. Primary Analysis of TRAVERSE: A Phase 1/2a Study to Assess Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost HIV Vaccine Regimens. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 18–18.
Journal cover image

Published In

AIDS RESEARCH AND HUMAN RETROVIRUSES

EISSN

1931-8405

ISSN

0889-2229

Publication Date

October 1, 2018

Volume

34

Start / End Page

18 / 18

Location

Madrid, SPAIN

Publisher

MARY ANN LIEBERT, INC

Conference Name

HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science

Related Subject Headings

  • Virology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences